Proton pump inhibitor or famotidine use and severe COVID-19 disease: a propensity score-matched territory-wide study

Jiandong Zhou¹, Xiansong Wang², Sharen Lee³, William Ka Kei Wu², Bernard Man Yung Cheung⁴, Qingpeng Zhang⁵, Gary Tse⁶

Affiliations

¹ School of Data Science, City University of Hong Kong, Kowloon, Hong Kong.
² Department of Anaesthesia and Intensive Care, Li Ka Shing Institute of Health Sciences, Hong Kong, China.
³ Cardiovascular Analytics Group, Laboratory of Cardiovascular Physiology, Hong Kong, China.
⁴ Department of Medicine, The University of Hong Kong, Hong Kong, China.
⁵ School of Data Science, City University of Hong Kong, Kowloon, Hong Kong garytse86@gmail.com qingpeng.zhang@cityu.edu.hk.
⁶ Tianjin Institute of Cardiology, Tianjin Medical University, Tianjin, China garytse86@gmail.com qingpeng.zhang@cityu.edu.hk.

PMID: 33277346
DOI: 10.1136/gutjnl-2020-323668

Comment

Proton pump inhibitor or famotidine use and severe COVID-19 disease: a propensity score-matched territory-wide study

Jiandong Zhou et al. Gut. 2021 Oct.

. 2021 Oct;70(10):2012-2013.

doi: 10.1136/gutjnl-2020-323668. Epub 2020 Dec 4.

Authors

Jiandong Zhou¹, Xiansong Wang², Sharen Lee³, William Ka Kei Wu², Bernard Man Yung Cheung⁴, Qingpeng Zhang⁵, Gary Tse⁶

Affiliations

¹ School of Data Science, City University of Hong Kong, Kowloon, Hong Kong.
² Department of Anaesthesia and Intensive Care, Li Ka Shing Institute of Health Sciences, Hong Kong, China.
³ Cardiovascular Analytics Group, Laboratory of Cardiovascular Physiology, Hong Kong, China.
⁴ Department of Medicine, The University of Hong Kong, Hong Kong, China.
⁵ School of Data Science, City University of Hong Kong, Kowloon, Hong Kong garytse86@gmail.com qingpeng.zhang@cityu.edu.hk.
⁶ Tianjin Institute of Cardiology, Tianjin Medical University, Tianjin, China garytse86@gmail.com qingpeng.zhang@cityu.edu.hk.

PMID: 33277346
DOI: 10.1136/gutjnl-2020-323668

No abstract available

Keywords: COVID-19; proton pump inhibition.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Comment on

Severe clinical outcomes of COVID-19 associated with proton pump inhibitors: a nationwide cohort study with propensity score matching.
Lee SW, Ha EK, Yeniova AÖ, Moon SY, Kim SY, Koh HY, Yang JM, Jeong SJ, Moon SJ, Cho JY, Yoo IK, Yon DK. Lee SW, et al. Gut. 2021 Jan;70(1):76-84. doi: 10.1136/gutjnl-2020-322248. Epub 2020 Jul 30. Gut. 2021. PMID: 32732368
Do proton pump inhibitors influence SARS-CoV-2 related outcomes? A meta-analysis.
Li GF, An XX, Yu Y, Jiao LR, Canarutto D, Yu G, Wang G, Wu DN, Xiao Y. Li GF, et al. Gut. 2021 Sep;70(9):1806-1808. doi: 10.1136/gutjnl-2020-323366. Epub 2020 Nov 10. Gut. 2021. PMID: 33172925 Free PMC article. No abstract available.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- HighWire
- Ovid Technologies, Inc.
Other Literature Sources
- H1 Connect - Access expert opinions and insights on biomedical research.
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Proton pump inhibitor or famotidine use and severe COVID-19 disease: a propensity score-matched territory-wide study

Affiliations

Proton pump inhibitor or famotidine use and severe COVID-19 disease: a propensity score-matched territory-wide study

Authors

Affiliations

Conflict of interest statement

Comment on

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical